Opt-in vs. Opt-out for Breast Cancer Screening

Sponsor
VA Puget Sound Health Care System (U.S. Fed)
Overall Status
Not yet recruiting
CT.gov ID
NCT05313737
Collaborator
(none)
871
1
2
4.4
196.4

Study Details

Study Description

Brief Summary

This is a randomized controlled trial that will evaluate the effectiveness two different outreach strategies for a population-based breast cancer screening program at the VA Puget Sound among average risk female Veterans who are due for breast cancer screening.

Condition or Disease Intervention/Treatment Phase
  • Other: Automated message
  • Other: Opt-out scheduling
N/A

Detailed Description

This is a prospective, randomized controlled trial that will evaluate the effectiveness of two different outreach strategies in improving adherence to breast cancer screening via mammography.

Average risk female Veterans who are due for breast cancer screening (defined as aged 45-75 with no previous history of bilateral mastectomy, not under hospice care, and alive at the time of screening) will be identified through administrative data.

Veterans eligible for enrollment into the trial will be randomized in a 1:1 allocation using permuted block randomization (with random block sizes of 2 and 4) to the following interventions:

Arm 1: Automated phone opt-in message Intervention Type: Audiocare message requiring Veteran to confirm that they would like to participate in screening and have consult sent Arm 2: Opt-out scheduling Intervention Type: Consult automatically sent and Veteran called to schedule screening

Randomization will be stratified within arms by prior screening status (prior screener vs. never screener).

The study's primary outcome of interest is screening completion at 100 days post randomization. The study's secondary outcome of interest is screening scheduling at 100 days post randomization. Subgroup analysis aim 1 will explore whether the differences in breast cancer screening completion between investigational groups varies according to the Veterans' race/ethnicity. Subgroup analysis aim 2 will explore whether the differences in breast cancer screening scheduling between investigational groups varies according to the Veterans' race/ethnicity. Enrollment in the trial will occur between March 1, 2022 and August 31, 2022.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
871 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Investigator)
Primary Purpose:
Screening
Official Title:
Opt-in vs. Opt-out Mammography Screening Outreach: a Randomized Controlled Trial
Anticipated Study Start Date :
Apr 18, 2022
Anticipated Primary Completion Date :
Aug 31, 2022
Anticipated Study Completion Date :
Aug 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Automated phone opt-in message

Audiocare message requiring Veteran to confirm that they would like to participate in screening and have consult sent

Other: Automated message
Automated message via phone call (audiocare)

Experimental: Opt-out scheduling

Consult automatically sent and Veteran called to schedule screening

Other: Opt-out scheduling
Scheduling via non-automated phone call

Outcome Measures

Primary Outcome Measures

  1. Percentage of mammograms completed at 100 days post randomization [100 days post randomization]

    Percent of mammograms completed

Secondary Outcome Measures

  1. Percentage of mammograms scheduled at 100 days post randomization [100 days post randomization]

    Percent of mammograms scheduled

Other Outcome Measures

  1. Percentage of mammograms cancelled at 100 days post randomization [100 days post randomization]

    Percent of mammograms cancelled

  2. Percentage of mammograms active at 100 days post randomization [100 days post randomization]

    Percent of mammograms active

Eligibility Criteria

Criteria

Ages Eligible for Study:
45 Years to 75 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • female Veterans aged 45-75

  • assigned to a primary care provider at the VA Puget Sound as of January 1, 2022 with at least 1 year of prior data available

  • due for breast cancer screening (have not had a mammogram in the last 12 months)

Exclusion Criteria:
  • must not be any indication of current receipt of hospice care

  • no record of recent death in the administrative data

  • not scheduled for either a screening or diagnostic mammogram within the following 12 weeks from assessment.

  • not have a personal history of bilateral mastectomy.

Contacts and Locations

Locations

Site City State Country Postal Code
1 VA Puget Sound Health Care System Seattle Washington United States 98108

Sponsors and Collaborators

  • VA Puget Sound Health Care System

Investigators

  • Principal Investigator: Ashok Reddy, MD, VA Puget Sound Health Care System
  • Principal Investigator: Stefanie Deeds, MD, VA Puget Sound Health Care System

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Alaina Mori, Staff Physician, VA Puget Sound Health Care System
ClinicalTrials.gov Identifier:
NCT05313737
Other Study ID Numbers:
  • MAMMoutreach
First Posted:
Apr 6, 2022
Last Update Posted:
Apr 6, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Alaina Mori, Staff Physician, VA Puget Sound Health Care System
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 6, 2022